Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes-Reference-Cited by-同舟云学术

Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes

Published:2021-06 Issue: Volume:66 Page:102458
ISSN:2049-0801
Container-title:Annals of Medicine and Surgery
language:en
Short-container-title:Annals of Medicine and Surgery

Author:

Carr B.I.,Guerra V.,Donghia R.,Yilmaz S.

Funder

NIH

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference35 articles.

1. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study;Pirisi;J. Canc. Res. Clin. Oncol.,1998

2. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study;Carr;Hepatology International,2010

3. Macroscopic portal vein thrombosis in HCC patients;Akkiz;Canadian J Gastroenterol and Hepatol,2018

4. C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors;Carr;Clin Pract (London),2018

5. Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics;Suner;J Transl Sci,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acetazolamide suppresses the progression of hepatocellular carcinoma induced by diethylnitrosamine in Wistar albino rats;Fundamental & Clinical Pharmacology;2024-08-20

2. Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study;Liver Cancer;2024-04-10

3. α‐FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma;International Journal of Cancer;2023-11-23